Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,366
Closed -$7.09K 3223
2023
Q1
$7.09K Hold
9,366
﹤0.01% 2810
2022
Q4
$10.3K Hold
9,366
﹤0.01% 2800
2022
Q3
$20K Hold
9,366
﹤0.01% 2532
2022
Q2
$32K Hold
9,366
﹤0.01% 2284
2022
Q1
$47K Hold
9,366
﹤0.01% 2100
2021
Q4
$59K Hold
9,366
﹤0.01% 2031
2021
Q3
$74K Hold
9,366
﹤0.01% 1883
2021
Q2
$70K Buy
9,366
+4,937
+111% +$34.5K ﹤0.01% 1965
2021
Q1
$27K Buy
4,429
+495
+13% +$3.81K ﹤0.01% 2436
2020
Q4
$22K Hold
3,934
﹤0.01% 2428
2020
Q3
$26K Hold
3,934
﹤0.01% 2248
2020
Q2
$35K Buy
+3,934
New +$11.3K ﹤0.01% 2049

Other funds holding VXRT

Ameritas Investment Partners's VXRT Position: Q2 2023 in Review

Ameritas Investment Partners sold out of Vaxart (VXRT) in Q2 2023, closing a stake of 9,366 shares — an estimated $7.09K sold.

Ameritas Investment Partners first reported a position in VXRT in Q2 2020 and held it in 12 quarters. The position peaked at $74K in Q3 2021. 111 funds tracked by Wall St. Rank hold VXRT as of Q2 2023.

  • Ameritas Investment Partners reported no remaining Vaxart position as of Q2 2023 after selling out during the quarter.
  • Ameritas Investment Partners sold 9,366 Vaxart shares in Q2 2023, an estimated $7.09K.
  • Ameritas Investment Partners first reported a position in Vaxart in Q2 2020 and held it in 12 quarters.
  • Ameritas Investment Partners's Vaxart position peaked at $74K in Q3 2021.
  • 111 funds tracked by Wall St. Rank held Vaxart as of Q2 2023.

Based on Ameritas Investment Partners's 13F filing for Q2 2023, filed 11 Aug 2023.